Controversies in the pharmacological management of acute asthma in children;Controvérsias no manejo farmacológico da asma aguda infantil

Jornal de Pediatria

Volumn 78, Issue SUPPL. 2, 2002, Pages

  Amantéa, Sérgio Luís ^a,c   Sánchez, Ignacio ^c   Piva, Jefferson Pedro ^b   Garcia, Pedro Celiny Ramos ^b  

^a FFCMPA   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UTI Pediat Hosp Sao Lucas PUCRS ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; METHYLXANTHINE; PREDNISONE; SALBUTAMOL;

ASTHMA; CHILD; CLINICAL TRIAL; CORTICOSTEROID THERAPY; FACTUAL DATABASE; HUMAN; MEDICAL LITERATURE; MEDICAL NEBULIZER; MEDLINE; METERED DOSE INHALER; REVIEW; TREATMENT OUTCOME;

EID: 0036868191     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/jped.894     Document Type: Review

References (53)

1. Werner HA. Status asthmaticus in children: A Review. Chest 2001;119:1913-29.
2. Bohn D, Kissoon N. Acute asthma. Pediatr Crit Care Med 2001;2:151-63.
3. Rowe BH, Edmonds ML, Spooner CH, Camargo CA. Evidence-based treatments for acute asthma. Respir Care 2001;46:1380-90.
4. Fritscher CC, Solé D, Rosário N. III Consenso Brasileiro no Manejo da Asma. J Pneumol 2002;28 Suppl 1:4-28.
5. Smith SR, Strunk RC. Acute asthma in the pediatric emergency department. Pediatr Clin North Am 1999;46:1145-65.
6. Zar HJ, Weinberg EG, Binns HJ, Gallie F, Mann MD. Lung deposition of aerosol - A comparison of different spacers. Arch Dis Child 2000;82:495-8.
7. Piva JP, Garcia PCR. More, more, and even more β2-adrenergic agents for treating acute asthma in children: Is the "adrenergic approach" the only way? Pediatr Crit Care Med 2002;3:202-3.
8. Isles AF, Newth CJL. Management of acute asthma in children. Baillieres Clin Paediatr 1995;3:341-78.
9. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990;336:1396-99.
10. Gibson PG, Norzila MZ, Fakes K, Simpsom J, Henry RL. Pattern of airway inflammation and its determinants in children with acute severe asthma. Pediatr Pulmonol 1999;28:261-70.
11. Jones MA, Wagener JS. Managing acute pediatric asthma: Keeping it short. J Pediatr 2001;139:3-5.
12. Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Engl J Med 1986;315:870-4.
13. Parkin P, Saunders NR, Diamond A, Winders PM, Mac Arthur C. Randomized trial spacer vs. nebulizer for acute asthma. Arch Dis Child 1995;72;239-40.
14. Calacone A, Afilalo M, Wolkone N, Kreisman H. A comparison of albuterol administered by metered dose inhaler or wet nebulizer in acute asthma. Chest 1993;104:835-41.
15. Schuh S, Johnson DW, Stephens D, Callahan S, Winders P, Canny GJ. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr 1999;135:22-7.
16. Kerem E, Levison H, Schuh S, O'Brodovich H, Reisman J, Bentur L, et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313-7.
17. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers: Success and cost savings in a large acute care hospital. Chest 1992;101:305-8.
18. Donaldson L. Large-volume plastic spacers in asthma: Should be more used. BMJ 1992;305:598-9.
19. Rubilar L, Castro-Rodríguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol 2000;29:264-9.
20. Closa RM, Ceballos JM, Gómez-Papí A, Sánchez Galiana A, Gutiérrez C, Marti-Henneber C. Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatr Pulmonol 1998;26:344-8.
21. Tal A, Golan H, Graver N, Ayiram M, Albin D, Quastel MR. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996;128:479-84.
22. British Thoracic, Paediatric and Emergency Medicine Associations. Guidelines on the management of asthma. Thorax 1993;48 Suppl 2:1-24.
23. Chou K, Cunningham S, Crain E. Metered-doses inhalers with spacers vs nebulisers for pediatric asthma. Arch Pediatr Adolesc Med 1995;149:201-5.
24. Yung-Zen L, Kue-Hsiung H. Metered-dose inhaler and nebuliser in acute asthma. Arch Dis Child 1995;72:214-8.
25. Amirav I, Newhouse MT. Metered-dose inhaler accessory devices in acute asthma. Efficacy and comparison with nebulizers: A literature review. Arch Pediatr Adolesc Med 1997;151:876-82.
26. Fuglsang G, Pedersen S. Comparison of nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis 1986;69:109-13.
27. Newhouse MT, Chapman KR, Mc Callum AL. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Lancet 1996;110:595-603.
28. Cates CJ, Rowe BH, Bara A. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2002;(2):CD000052.
29. Bohn D, Kalloghlian A, Jenkins J, Edmonds J, Barker G. Intravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med 1984;12:892-96.
30. Piva J, Amantéa S, Garcia P. Treatment of Severe Acute Asthma in the Child. Update Intens Care Emerg Med 1996;25:344-53.
31. Taylor D, Hancox R. Interactions between corticosteroids and Beta agonists. Thorax 2000;55:595-602.
32. O'Callaghan C, Barry P. How to choose delivery devices for asthma. Arch Dis Child 2000;82:185-91.
33. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, et al. The effect of common polymorphisms of the Beta2-adrenergic agents receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-5.
34. Browne G, Lam L. Single dose intravenous salbutamol bolus for managing children with severe acute asthma in the emergency department: Re-analysis of data. Ped Crit Care Med 2002;3:117-23.
35. Browne GJ, Penna AS, Phung X, Soo M. Randomized trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997;349:301-5.
36. Santana J, Barreto S, Piva J, Garcia PC. Controlled study on intravenous magnesium sulfate or salbutamol in early treatment of severe acute asthma attack in children. J Pediatr (Rio J) Disponível em: http://www.jped.com.br/conteudo/01-77-04-279/ ing.asp. Acessado em 04 de novembro de 2002.
37. Stephanopoulos DE, Monge R, Schell KH, Wyckoff P, Peterson BM. Continuous intravenous terbutaline for pediatric status asthmaticus. Crit Care Med 1998;26:1744-8.
38. Piva JP, Amantéa S, Rosso A Maia TR, Giugno K. Intravenous Terbutaline In PICU. Intens Care Med 1996;22 Suppl 2:188.
39. Piva JP, Amantéa S, Rosso A, Zambonato S, Maia TR, Giugno K. Terbutalina endovenosa em crianças. J Pediatr (Rio J) 1998;74:441-6.
40. Shan F. Dose of intravenous infusion of terbutaline and salbutamol. Crit Care Med 2000;28:2179-80.
41. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA Jr, Rowe BH. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev. 2001;(2):CD002988.
42. Burgess C, Pearce N, Thiruchelvam R, Wilkinson R, Linaker C, Woodman K, et al. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J 1994;7:498-503.
43. Poe RH, Israel RH. Teophylline: Still a reasonable choice? J Respir Dis 1994;15:19-32.
44. Carter E, Cruz M, Chesrown S, Shieh G, Reilly K, Hendeles L Efficacy of intravenously administered theophyline in children hospitalized with severe asthma. J Pediatr 1993;122:470-6.
45. DiGiulio GA, Kercsmar CM, Krug SE, Alpert SE, Marx CM. Hospital treatment of asthma: Lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr 1993;122;464-9.
46. Goodman DC, Littenberg B, O'Connor GT, Brooks JG. Theophylline in acute childhood asthma: A meta-analysis of its efficacy. Pediatr Pulmonol 1996;21:211-18.
47. Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child 1998;79:405-10.
48. Ream RS, Loftis LL, Albers GM, Becker BA, Lynch RE, Mink RB. Efficacy of IV theophylline in children with severe status asthmaticus. Chest 2001;119:1480-88.
49. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: Time for reappraisal? Eur Respir J 1994;7:579-91.
50. Littenberg B. Aminophylline treatment in severe, acute asthma. A Meta-Analysis. JAMA 1988;259:1678-84.
51. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000;154:979-83.
52. Scarfone RJ, Loiselle JM, Joffe MD, Mull CC, Stiller S, Thompson K, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med 2000;36:572-8.
53. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000;2:CD001490.